Literature DB >> 31074777

SGLT2 inhibitors: reviving the sodium-hydrogen exchanger cardioprotection hypothesis?

Sapna Arjun1, Robert M Bell1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31074777     DOI： 10.1093/cvr/cvz105

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  3 in total

1.  Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition.

Authors:  Nitin A Das; Andrea J Carpenter; Anthony Belenchia; Annayya R Aroor; Makoto Noda; Ulrich Siebenlist; Bysani Chandrasekar; Vincent G DeMarco
Journal:  Cell Signal       Date:  2019-12-17       Impact factor: 4.315

Review 2.  A state-of-the-art review of the current role of cardioprotective techniques in cardiac transplantation.

Authors:  Paul P Cullen; Steven S Tsui; Noel M Caplice; John A Hinchion
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-05-10

Review 3.  Mitochondrial Ca2+, redox environment and ROS emission in heart failure: Two sides of the same coin?

Authors:  Sonia Cortassa; Magdalena Juhaszova; Miguel A Aon; Dmitry B Zorov; Steven J Sollott
Journal:  J Mol Cell Cardiol       Date:  2020-12-07       Impact factor: 5.000
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.